Cargando…

Efficacy of 1, 5, and 20 mg oral sildenafil in the treatment of adults with pulmonary arterial hypertension: a randomized, double-blind study with open-label extension

BACKGROUND: In a previous study, 6-minute walk distance (6MWD) improvement with sildenafil was not dose dependent at the 3 doses tested (20, 40, and 80 mg 3 times daily [TID]). This study assessed whether lower doses were less effective than the approved 20-mg TID dosage. METHODS: Treatment-naive pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vizza, Carmine Dario, Sastry, B. K. S., Safdar, Zeenat, Harnisch, Lutz, Gao, Xiang, Zhang, Min, Lamba, Manisha, Jing, Zhi-Cheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5322647/ https://www.ncbi.nlm.nih.gov/pubmed/28228114 http://dx.doi.org/10.1186/s12890-017-0374-x

Ejemplares similares

Sildenafil dosed concomitantly with bosentan for adult pulmonary arterial hypertension in a randomized controlled trial
por: Vizza, Carmine Dario, et al.
Publicado: (2017)

The efficacy and long-term safety of a triple combination of 80 mg telmisartan, 5 mg amlodipine and 12.5 mg hydrochlorothiazide in Japanese patients with essential hypertension: a randomized, double-blind study with open-label extension
por: Higaki, Jitsuo, et al.
Publicado: (2017)

Efficacy of Sildenafil in Infants with Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension
por: Dillon, Kacie, et al.
Publicado: (2023)

Ocular safety of sildenafil citrate when administered chronically for pulmonary arterial hypertension: results from phase III, randomised, double masked, placebo controlled trial and open label extension
por: Wirostko, Barbara M, et al.
Publicado: (2012)

Safety of sildenafil citrate: review of 67 double-blind placebo-controlled trials and the postmarketing safety database
por: Giuliano, F, et al.
Publicado: (2010)

Reducing the risk of fetal distress with sildenafil study (RIDSTRESS): a double-blind randomised control trial
por: Dunn, Liam, et al.
Publicado: (2016)

Fast Cicatrization of Extensive Livedoid Vasculopathy Ulcers under Treatment with Sildenafil
por: Lopes, Lediane Moreira, et al.
Publicado: (2017)

A randomized, double-blind, placebo-controlled study to evaluate sildenafil, ambrisentan combination therapy in pulmonary hypertension, particularly of Eisenmenger syndrome
por: Mohammed, Shaadab, et al.
Publicado: (2021)

Improvement in erection hardness and intercourse success with first dose of sildenafil citrate 100 mg
por: Mulhall, John P, et al.
Publicado: (2013)

Effect of transition from sitaxsentan to ambrisentan in pulmonary arterial hypertension
por: Safdar, Zeenat
Publicado: (2011)

Prophylactic Sildenafil in Preterm Infants at Risk of Bronchopulmonary Dysplasia: A Pilot Randomized, Double-Blinded, Placebo-Controlled Trial
por: Abounahia, Fouad F., et al.
Publicado: (2019)

Efficacy and safety of avanafil as compared with sildenafil in the treatment of erectile dysfunction: A randomized, double blind, multicenter clinical trial
por: Kumar, Manish, et al.
Publicado: (2022)

Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: a multicenter, double-blind, randomized clinical trial
por: Bermejo, Javier, et al.
Publicado: (2018)

Efficacy of Milrinone Plus Sildenafil in the Treatment of Neonates with Persistent Pulmonary Hypertension in Resource-Limited Settings: Results of a Randomized, Double-Blind Trial
por: El-Ghandour, Mamdouh, et al.
Publicado: (2020)

Sildenafil in the treatment of pulmonary hypertension
por: Barnett, Christopher F, et al.
Publicado: (2006)

Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12 064 survivors of myocardial infarction: a double-blind randomised trial
por: Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH) Collaborative Group
Publicado: (2010)

A randomized, double-blind study to evaluate the acid-inhibitory effect of vonoprazan (20 mg and 40 mg) in patients with proton-pump inhibitor-resistant erosive esophagitis
por: Iwakiri, Katsuhiko, et al.
Publicado: (2017)

Efficacy and safety of vilazodone 20 and 40 mg in major depressive disorder: a randomized, double-blind, placebo-controlled trial
por: Mathews, Maju, et al.
Publicado: (2015)

Pharmacokinetic and Pharmacodynamic Comparison of Sildenafil‐Bosentan and Sildenafil‐Ambrisentan Combination Therapies for Pulmonary Hypertension
por: Hakamata, A, et al.
Publicado: (2016)

Why sildenafil and sildenafil citrate monohydrate crystals are not stable?
por: Sawatdee, Somchai, et al.
Publicado: (2015)

Comment on Topyła-Putowska et al. Echocardiography in Pulmonary Arterial Hypertension: Comprehensive Evaluation and Technical Considerations. J. Clin. Med. 2021, 10, 3229
por: Manzi, Giovanna, et al.
Publicado: (2022)

Sildenafil citrate as a medical expulsive therapy for distal ureteric stones: A randomised double-blind placebo-controlled study
por: Shokeir, Ahmed A., et al.
Publicado: (2016)

Intravenous sildenafil citrate and post-cardiac surgery acute kidney injury: a double-blind, randomised, placebo-controlled trial
por: Kumar, Tracy, et al.
Publicado: (2020)

Morning and evening efficacy evaluation of rupatadine (10 and 20 mg), compared with cetirizine 10 mg in perennial allergic rhinitis: a randomized, double-blind, placebo-controlled trial
por: Marmouz, Farid, et al.
Publicado: (2011)

Mifepristone 5 mg versus 10 mg for emergency contraception: double-blind randomized clinical trial
por: Carbonell, Josep Lluis, et al.
Publicado: (2015)

Safety and tolerability of vortioxetine (15 and 20 mg) in patients with major depressive disorder: results of an open-label, flexible-dose, 52-week extension study
por: Jacobsen, Paula L., et al.
Publicado: (2015)

Chronic Thromboembolic Pulmonary Hypertension Medical Management
por: Logue, Ryan, et al.
Publicado: (2021)

Assessment of Denosumab in Korean Postmenopausal Women with Osteoporosis: Randomized, Double-Blind, Placebo-Controlled Trial with Open-Label Extension
por: Koh, Jung-Min, et al.
Publicado: (2016)

Update on pulmonary hypertension complicating chronic obstructive pulmonary disease
por: Jyothula, Soma, et al.
Publicado: (2009)

Goiter in a Patient with Pulmonary Arterial Hypertension Treated with Epoprostenol
por: Abughazaleh, Shaadi, et al.
Publicado: (2020)

Sildenafil in pediatric pulmonary arterial hypertension
por: Dhariwal, AK, et al.
Publicado: (2015)

The hypertensive effect of sorafenib is abolished by sildenafil
por: Dabiré, Hubert, et al.
Publicado: (2020)

Morning and evening efficacy evaluation of rupatadine (10 and 20 mg), compared with cetirizine 10 mg in perennial allergic rhinitis: a randomized, double-blind, placebo-controlled trial [Corrigendum]
Publicado: (2015)

Effect of spironolactone use in pulmonary arterial hypertension – analysis from pivotal trial databases
por: Safdar, Zeenat, et al.
Publicado: (2021)

Systematic Evaluation of the T30 Neurostimulator Treatment for Tinnitus: A Double-Blind Randomised Placebo-Controlled Trial with Open-Label Extension
por: Hall, Deborah Ann, et al.
Publicado: (2022)

Efficacy, safety and tolerability of bosentan as an adjuvant to sildenafil and sildenafil alone in persistant pulmonary hypertension of newborn (PPHN)
por: Vijay Kumar, J.R., et al.
Publicado: (2021)

Use of off-label compounded oral sildenafil in the management of persistent pulmonary hypertension of the newborn: A case report
por: Daniyan, Olapeju, et al.
Publicado: (2022)

Comparison of preventive effect of sildenafil and therapeutic effect of sildenafil treatment in rats with monocrotaline-induced pulmonary arterial hypertension
por: YOSHIYUKI, Rieko, et al.
Publicado: (2016)

SILDENAFIL (VIAGRA) AND THE HEART
por: Chamsi-Pasha, Hassan
Publicado: (2001)

Sildenafil in Infants and Children
por: Simonca, Larisa, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_5ufu0ugubunrnu00o393gcdajj